Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics.
Parkinson's disease is a neurodegenerative disorder characterized by Lewy bodies, a pathological hallmark comprised mostly of aggregated alpha synuclein. Accumulating evidence demonstrates the association of smaller oligomeric aggregates to disease etiology and many therapeutic approaches are a...
Enregistré dans:
Auteurs principaux: | Hemi Dimant, Liya Zhu, Laura N Kibuuka, Zhanyun Fan, Bradley T Hyman, Pamela J McLean |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dee3e3b4dd7e4f65acf6ea5d3b17cf92 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
par: Gessica Sala, et autres
Publié: (2021) -
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
par: Iosif Pediaditakis, et autres
Publié: (2021) -
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
par: Gessica Sala, et autres
Publié: (2021) -
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
par: Rachel Kelly, et autres
Publié: (2021) -
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
par: Caitriona McLean, et autres
Publié: (2009)